Global Zika Vaccines Market Size By Vaccine Type(Inactivated Vaccine, Purified Inactivated Vaccine, DNA Vaccine), By Application (Clinics, Academic and Research, Hospitals), By Geographic Scope And Forecast
Report ID: 39420|No. of Pages: 202
Global Zika Vaccines Market Size By Vaccine Type(Inactivated Vaccine, Purified Inactivated Vaccine, DNA Vaccine), By Application (Clinics, Academic and Research, Hospitals), By Geographic Scope And Forecast
Zika Vaccines Market Size And Forecast
Zika Vaccines Market size was valued at USD 13,691 Million in 2024 and is projected to reach USD 19,789 Million by 2031, growing at a CAGR of 5.4% from 2024 to 2031.
The increased prevalence of Zika virus disease in countries is driving the global Zika Vaccines Market forward. Major pharmaceutical companies that have increased the investment in R&D for the production of new vaccines is driving the global market’s expansion. In addition, there has been an increase in outreach campaigns and a partnership study for vaccine development with the World Health Organization which is driving the growth of Zika Vaccines Market. The Global Zika Vaccines Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Zika Vaccines Market Definition
Zika virus (ZIKV), also known as a flavivirus, that is from the Flaviviridae family, is a mosquito-borne disease that spreads to humans through mosquitos, blood transfusions, sex, and from an infected pregnant woman to her baby. After biting a zika-infected human, a mosquito becomes infected with the virus and spreads it to anyone they sting. Infection with the Zika virus may result in neurological abnormalities and congenital birth defects in the fetus. Zika vaccines are being designed to help people prevent and manage diseases caused by the Zika virus.
There are many varieties of vaccines used to protect against the Zika virus, including mRNA vaccines, DNA vaccines, and inactivated vaccines. In addition, the virus can be transmitted from an infected pregnant woman to her fetus. PCR is used for the diagnosis of the infection. However, only 1 out of every 4 people with the virus has the risk of developing symptoms. In November 2016, the World Health Organization (WHO) announced that the Zika virus is no longer a threat to public health, which has been an international concern since the major cases of the virus are asymptomatic.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=39420
Global Zika Vaccines Market Overview
The increasing prevalence of the active Zika virus as well as increased concern about the consequences of the Zika virus has increased the market for Zika vaccines and is the primary factor driving the global Zika virus vaccine demand. The rising prevalence of Zika fever is fueling the production of effective vaccines. The growing public understanding of the virus is encouraging the use of these vaccines which in turn is driving the market. Increased investment in vaccine research and development, as well as favorable government policies, are also the growth drivers for the Zika Vaccines Market.
In addition, the increase in demand for zika virus and advancements in vaccine technologies are expected to help in business growth and development. However, the factors restraining the market growth and development are a lack of affordability and a lack of recognition and awareness in remote areas. Also, the lack of knowledge in using advanced technology in underdeveloped countries is also restraining the market growth. In addition, these vaccines might cause some harmful effects on the body of individuals which in turn can restrain the market growth.
Global Zika Vaccines Market: Segmentation Analysis
The Global Zika Vaccines Market is segmented based on Vaccine Type, Application, and Geography.
Zika Vaccines Market, By Vaccine Type
- Inactivated Vaccine
- Purified Inactivated Vaccine
- DNA Vaccine
Based on Vaccine Type, the market is bifurcated into Inactivated Vaccine, Purified Inactivated Vaccine, and DNA Vaccine. Inactivated Vaccine dominated the market in 2019 and is likely to continue in the forecast period. Purified Inactivated Vaccine has good market potentials in the forecast period owing to the evolution of modern medicines and equipment technologies.
Zika Vaccines Market, By Application
- Clinics
- Academic and Research
- Hospitals
- Others
Based on Application, the market is bifurcated into Clinics, Academic and Research, Hospitals, and Others. The hospital segment accounted for the strongest share in 2019, and this pattern is expected to continue. An increase in patients with Zika virus disease would necessitate hospitalization. Also, the early availability of new drugs in hospitals is expected to fuel the segment’s development.
Zika Vaccines Market, By Geography
- North America
- Europe
- Asia Pacific
- Rest of the world
Based on regional analysis, the Global Zika Vaccines Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. In 2019, the Rest of the world led the global Zika Vaccines Market, and this pattern is projected to continue over the years. The region’s domination can be due to a rise in people infected with the Zika virus in countries such as Brazil, Bolivia, and Peru, as well as the involvement of major players.
Key Players
The “Global Zika Vaccines Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Inovio Pharmaceuticals, Inc., Emergent BioSolutions Inc., Gilead Sciences Inc., Precigen, Inc., LUMOS PHARMA, Hawaii Biotech Inc., Sanofi, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, and Bharat Biotech.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Ace Matrix Analysis
The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
Market Attractiveness
The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Zika Vaccines market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
Porter’s Five Forces
The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. The porter’s five forces model can be used to assess the competitive landscape in global Zika Vaccines market, gauge the attractiveness of a certain sector, and assess investment possibilities.
Report Scope
| Report Attributes | Details |
|---|---|
| Study Period | 2021-2031 |
| Base Year | 2024 |
| Forecast Period | 2024-2031 |
| Historical Period | 2021-2023 |
| Key Companies Profiled | Inovio Pharmaceuticals, Inc., Emergent BioSolutions Inc., Gilead Sciences Inc., Precigen, Inc., LUMOS PHARMA, Hawaii Biotech Inc., Sanofi, GlaxoSmithKline plc. |
| Segments Covered |
|
| Customization scope | Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF GLOBAL ZIKA VACCINES MARKET
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Assumptions
1.5 Limitations
2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
2.1 Data Mining
2.2 Data Triangulation
2.3 Bottom-Up Approach
2.4 Top-Down Approach
2.5 Research Flow
2.6 Key Insights from Industry Experts
2.7 Data Sources
3 EXECUTIVE SUMMARY
3.1 Market Overview
3.2 Ecology Mapping
3.3 Absolute Market Opportunity
3.4 Market Attractiveness
3.5 Global Zika Vaccines Market Geographical Analysis (CAGR %)
3.6 Global Zika Vaccines Market, By Vaccine Type (USD Million)
3.7 Global Zika Vaccines Market, By Application (USD Million)
3.8 Future Market Opportunities
3.9 Global Market Split
3.10 Product Life Line
4 GLOBAL ZIKA VACCINES MARKET OUTLOOK
4.1 Global Zika Vaccines Evolution
4.2 Drivers
4.2.1 Driver 1
4.2.2 Driver 2
4.3 Restraints
4.3.1 Restraint 1
4.3.2 Restraint 2
4.4 Opportunities
4.4.1 Opportunity 1
4.4.2 Opportunity 2
4.5 Porters Five Force Model
4.6 Value Chain Analysis
4.7 Pricing Analysis
4.8 Macroeconomic Analysis
5 GLOBAL ZIKA VACCINES MARKET, BY VACCINE TYPE
5.1 Overview
5.2 Inactivated Vaccine
5.3 Purified Inactivated Vaccine
5.4 DNA Vaccine
6 GLOBAL ZIKA VACCINES MARKET, BY APPLICATION
6.1 Overview
6.2 Clinics
6.3 Academic and Research
6.4 Hospitals
6.5 Others
7 GLOBAL ZIKA VACCINES MARKET, BY GEOGRAPHY
7.1 Overview
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Argentina
7.5.3 Rest of Latin America
7.6 Middle-East and Africa
7.6.1 UAE
7.6.2 Saudi Arabia
7.6.3 South Africa
7.6.4 Rest of Middle-East and Africa
8 GLOBAL ZIKA VACCINES MARKET COMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Ranking
8.3 Key Developments
8.4 Company Regional Footprint
8.5 Company Industry Footprint
8.6 ACE Matrix
9 COMPANY PROFILES
9.1 Inovio Pharmaceuticals Inc
9.1.1 Company Overview
9.1.2 Company Insights
9.1.3 Product Benchmarking
9.1.4 Key Development
9.1.5 Winning Imperatives
9.1.6 Current Focus & Strategies
9.1.7 Threat from Competition
9.1.8 SWOT Analysis
9.2 Emergent BioSolutions Inc
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Gilead Sciences Inc
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Precigen Inc
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 LUMOS PHARMA
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Hawaii Biotech Inc
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 Sanofi
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 GlaxoSmithKline plc
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 Takeda Pharmaceutical Company Limited
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments
9.10 Bharat Biotech
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments
10 VERIFIED MARKET INTELLIGENCE
10.1 About Verified Market Intelligence
10.2 Dynamic Data Visualization
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
